TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Phase of Trial: Phase IV
Latest Information Update: 17 Mar 2015
At a glance
- Drugs Dexamethasone (Primary)
- Indications Macular degeneration; Uveitis
- Focus Therapeutic Use
- Acronyms TAHOE
- 17 Mar 2015 Last checked against ClinicalTrials.gov record.
- 10 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 16 Jul 2014 New trial record